Understanding how lung immune cells help heal lung injuries
Lung Macrophage Programming in Acute Lung Injury
This study is looking at how certain immune cells in the lungs help reduce inflammation and support healing after lung injuries, with the goal of finding ways to improve recovery for people with lung diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | National Jewish Health NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project ID | NIH-10766735 on NIH RePORTER |
What this research studies
This research investigates the role of lung macrophages, a type of immune cell, in managing inflammation and promoting healing in acute lung injuries. It aims to understand how different types of macrophages function during lung inflammation and repair processes. By studying these cells, researchers hope to identify mechanisms that could enhance recovery from lung diseases. The approach involves analyzing how these macrophages are programmed and how they interact with other cells in the lung.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from acute inflammatory lung diseases, such as pneumonia or acute respiratory distress syndrome.
Not a fit: Patients with chronic lung conditions or those who do not have acute lung injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery from acute lung injuries and related diseases.
How similar studies have performed: Previous research has shown promising results in understanding macrophage roles in lung inflammation, suggesting that this approach could lead to significant advancements.
Where this research is happening
Denver, United States
- National Jewish Health — Denver, United States (Active)
Researchers
- Principal investigator: Janssen, William — National Jewish Health
- Study coordinator: Janssen, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.